Finished product reference
Artificial Tears (Hyaluronate Sodium / Ts-polysaccaride)
Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 10 mL
- List code
- 51906
- Pharmacologic class
- Ocular lubricant (sodium hyaluronate / tamarind seed polysaccharide)
What it is and how it works
Sodium hyaluronate and tamarind seed polysaccharide (TSP, a xyloglucan with mucin-like, mucoadhesive properties) act synergistically to increase tear-film viscosity and residence time, lubricating and protecting the ocular surface and supporting epithelial healing.
Indications
Symptomatic relief of dry eye and ocular surface discomfort, including that associated with contact lens wear and after ocular surgery.
Dosage and administration (summary)
1–2 drops into each affected eye as required, commonly three to four times daily.
Contraindications
Hypersensitivity to any component.
Warnings and precautions
Transient blurred vision may occur after instillation. Avoid contaminating the dropper tip. Seek medical review for persistent pain, redness or visual change.
Pregnancy
Considered safe for use in pregnancy.
Storage and supply
Store below 25 °C; use within the period stated after opening.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
- Gel · Ophthalmic · 0.2 % · 10 g50883
- Gel · Ophthalmic · 0.25 % · 0.5 g50308
- Gel · Ophthalmic · 0.25 % · 10 g50309
- Solution, Drops · Ophthalmic · 0.15 %/3 % · 10 mL52078
- Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 0.5 mL51905
- Solution, Drops · Ophthalmic · 0.15 % · 0.35 mL51900
- Solution, Drops · Ophthalmic · 0.15 % · 0.5 mL52909
- Solution, Drops · Ophthalmic · 0.15 % · 10 mL52910
- Solution, Drops · Ophthalmic · 0.2 %51703
- Solution, Drops · Ophthalmic · 0.3 % · 0.35 mL51990
- Solution, Drops · Ophthalmic · 0.4 % · 0.5 mL51904
- Solution, Drops · Ophthalmic · 0.4 % · 10 mL51907
- Solution, Drops · Ophthalmic · 0.5 % · 15 mL52004
- Gel · Ophthalmic · 0.2 % · 10 g19130
- Solution · Ophthalmic · 3.2 mg/1mL · 0.5 mL50429
- Solution · Ophthalmic · 3.2 mg/1mL · 10 mL51057
- Solution, Drops · Ophthalmic · 0.3 % · 0.5 mL51892
- Solution, Drops · Ophthalmic · 0.3 % · 10 mL51891
- Solution, Drops · Ophthalmic · 14 mg/1mL · 10 mL50647
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.